Enquiry/Quote
Amikacin 500 mg Injectable Solution bulk supplier for pharma manufacturers

Amikacin 500 Mg Injectable Solution Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 250 mg/2 mL, 500 mg/2 mL, 1 g/2 mL

Reference Brands: Amikin(Us & EU)

Category: Antibiotics

Amikacin inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, leading to faulty protein production and bacterial cell death. It provides rapid, broad-spectrum activity against serious gram-negative infections such as sepsis and pneumonia. Benefits include quick bacterial eradication, effective hospital use, and coverage of resistant bacteria when used properly. Amikacin 500 mg Injectable Solution is available in Injectable Solution and strengths such as 250 mg/2 mL, 500 mg/2 mL, 1 g/2 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Amikacin 500 mg Injectable Solution is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Amikacin 500 mg Injectable Solution can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Amikacin IV is approved in the EU and US for serious gram-negative bacterial infections. In the EU, brands like Amikin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. Due to its potent antibacterial activity and potential toxicity, strict prescribing controls and monitoring are enforced. For regulatory dossier support, compliance, and registration, visit PharmaTradz. We support seamless market access aligned with European and US standards for safe, effective antimicrobial therapy.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Amikacin injection is used to treat serious bacterial infections caused by susceptible Gram-negative organisms. These include infections of the respiratory tract, urinary tract, bones and joints, skin and soft tissues, intra-abdominal infections, septicemia, and hospital-acquired infections. It is often reserved for severe or resistant infections.

Amikacin injection is made from amikacin sulfate, a semi-synthetic aminoglycoside antibiotic derived from kanamycin. It works by inhibiting bacterial protein synthesis, leading to the destruction of bacteria.

Common trade names include Amikin, Amikacin Injection IP (generic), Amikace, Amistar, and Amipar.

Amikacin was originally marketed under the brand Amikin by Bristol-Myers Squibb. It is now manufactured by multiple pharmaceutical companies worldwide including Cipla, Sun Pharma, Lupin, and many other generic manufacturers.

The generic name is amikacin sulfate injection.

Brand names include Amikin, Amikace, Amistar, Amipar, and various other region-specific generics.

Amikacin injection is manufactured globally, with major production hubs in India, the United States, Europe, and other regions by both innovator and generic pharmaceutical companies.

Yes, Amikacin 500 mg Injectable Solution is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Amikacin 500 mg Injectable Solution is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Rifaximin

Strength:
100 mg/5 mL, 200 mg, 550 mg

Form: Tablet / Oral Suspension

Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)

View Details
Ceftaroline

Strength:
600 mg

Form: Injection

Reference Brands: Teflaro (USA), Zinforo (EU)

View Details
Secnidazole

Strength:
2 g

Form: Oral granules/ tablets

Reference Brands: Solosec (USA)

View Details
Omaveloxolone

Strength:
150 mg

Form: Tablets

Reference Brands: Skyclarys (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.